COVID vaccine acceptance in Libya
Willingness to take a COVID-19 vaccine rose with assumed efficacy—about 80% if efficacy was ≥90%, but only about 41% if 50%.
Source
Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study
What they did
A cross-sectional survey of the public and health-care groups in Libya assessed knowledge, attitudes, and acceptance of COVID-19 vaccination under different efficacy scenarios.
What they found
Among 15,087 respondents, acceptance was 79.6% for ≥90% efficacy, 60.6% for ≥70%, and 41.2% for 50%. Most respondents were general public; about one-quarter were students or clinicians.
The limits
What it doesn't show
Convenience/online sampling and hypothetical efficacy scenarios limit inference about later real uptake.
Key terms
- Vaccine acceptance
- Willingness to take a COVID-19 vaccine.
- Efficacy scenario
- Assumed vaccine effectiveness presented to respondents.
- KAP survey
- Knowledge, attitude, and practice/acceptance questionnaire.
- Health-care workers
- Doctors, nurses/paramedics, and medical students in the sample.
- Cross-sectional
- Single-time survey design.
- General population
- Non–health-worker respondents.
Flashcards
Want these cards to stick?
Save the deck to NoteFren and study it with spaced repetition.
Quiz yourself
N analysed:
Common questions
N analysed?
15,087.
Acceptance if ≥90% efficacy?
79.6%.
Acceptance if 50% efficacy?
41.2%.
Share general public?
73.7%.
More on Vaccination